Access comprehensive trade data for State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Eximpedia analyzes State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine export and import records, including data from 0 buyers and 37 suppliers. We provide an intelligence report of State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine import markets
Explore the State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
HS CODE | USD VALUE | SHIPMENTS | % |
---|---|---|---|
3004900000 | 26.95 | 54 | 14.32 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
3002150000 | 13.43 | 18 | 4.77 |
HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
3002120000 | 11.17 | 14 | 3.71 |
HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
3004390000 | 10.59 | 7 | 1.86 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
9018390000 | 5.69 | 101 | 26.79 |
INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES, INCLUDING SCIENTIGRAPHIC APPARATUS, OTHER ELECTROMEDICAL APPARATUS AND SIGHT-TESTING INSTRUMENTS |
COUNTRY | USD VALUE | SHIPMENTS | % |
---|---|---|---|
UNITED STATES | 13.38 | 81 | 21.49 |
GERMANY | 10.69 | 16 | 4.24 |
AUSTRIA | 9.36 | 15 | 3.98 |
BELGIUM | 8.62 | 15 | 3.98 |
GREAT BRITAIN | 7.05 | 5 | 1.33 |
PORT NAME | USD VALUE | SHIPMENTS | % |
---|---|---|---|
UA100110 | 69.88 | 330 | 87.53 |
UA100200 | 13.52 | 26 | 6.90 |
UA209190 | 3.39 | 13 | 3.45 |
UA100360 | 3.53 | 7 | 1.86 |
UA305130 | 0.05 | 1 | 0.27 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
MINISTRY OF HEALTH | 206.51 | 8344 |
SOCIAL SECURITY INSTITUTION | 231.08 | 35 |
BADM LIMITED LIABILITY COMPANY | 394.73 | 5166 |
JV OPTIMA FARM LIMITED | 400.43 | 5786 |
TURKISH PHARMACISTS ASSOCIATION ECONOMIC ENTERPRISE | 536.15 | 2196 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
TANNER PHARMA CH GMBH ON BEHALF OF MAXAID | 117.29 | 15 |
BIOGEN INTERNATIONAL GMBH | 127.48 | 115 |
BOEHRINGER INGELHEIM | 146.49 | 839 |
BMED INTERNATIONAL BUSINESS COMPANY LIMITED | 150.27 | 163 |
GEN ILAÇ INTERNATIONAL TRADING LIMITED | 244.44 | 236 |
If you are looking to establish relationship with State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine Automation you can save time by getting access to the key decision makers and get a detailed report.
Discover the State Enterprise Medical Purchase Of Ukraine State Enterprise Medical Purchase Of Ukraine with product description, import values, quantities, exporter name, country of origin and key destinations.
HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
---|---|---|---|---|---|---|
3004200000 | 1. PHARMACEUTICAL PRODUCTS - SODIUM COLISTIMETHATE 2,000,000 IU, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED MEASURES FOR HEALTH PROTECTION, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR THE TREATMENT OF CHILDREN WITH ONCOLOGICAL AND ONCOHEMATOLOGICAL DISEASES, AND TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FOR CHILDREN AND ADULTS """" DRUGS AND MEDICAL DEVICES UNDER THE BUDGET PROGRAM OF THE KPKVK 2301400. PHARMACOTHERAPEUTIC GROUP: ANTIBACTERIAL AGENTS. ATC CODE J01X B01 :- COLISTIN ZENTIVA (INN - SODIUM COLISTIMETHATE), POWDER FOR SOLUTION FOR INJECTIONS OR INFUSIONS 2,000,000 IU; 10 BOTTLES WITH POWDER IN A CARDBOARD BOX. ACTIVE SUBSTANCE: 1 BOTTLE CONTAINS: COLISTIMETHATE SODIUM 2,000,000 IU. SERIES 3166860., TOTAL - 15350 PCS., COUNTRY OF MANUFACTURE: DK; TRADE MARK: KOLISTIN ZENTIVA; MANUFACTURER: XELLIA PHARMACEUTICALS APSTESTING: XELLIA PHARMACEUTICALS LTD, HUNGARY""" | DENMARK | UKRAINE | 0 | ||
9018908400 | 1. MEDICAL PRODUCT, ASPIRATION SYSTEM FOR THROMBECTOMY IN CASE OF ISCHEMIC STROKE, CONSISTING OF: ASPIRATION PUMP, CONNECTING LINE, CONTAINER FOR COLLECTING ASPIRATED MATERIAL. IT IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE FIELD OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL DEVICES FOR HEALTH CARE INSTITUTIONS TO ENSURE THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"" , ACCORDING TO THE KPKVK BUDGET PROGRAM 2301400. ASPIRATION SYSTEM FOR THROMBECTOMY IN CASE OF ISCHEMIC STROKE, CONSISTING OF: RIPTIDE ASPIRATION PUMP (1PC), COMPLETE WITH A COLLECTION TANK WITH AN INTERMEDIATE RIPTIDE TUBE (5PCS) AND A WIDE RIPTIDE ASPIRATION TUBE (5PCS). A TOTAL OF 18 SYSTEMS.- ASPIRATION PUMP RIPTIDE, CATALOG NUMBER MAR-1000EU - 18 PIECES.- COLLECTION TANK WITH INTERMEDIATE TUBE RIPTIDE, CATALOG NUMBER МАС-1200 - 90 PIECES.- WIDE ASPIRATION TUBE RIPTIDE, CATALOG NUMBER МАТ-110-110 - 90 PIECES. MANUFACTURER - MICRO THERAPEUTICS INC. DBA EV3 NEUROVASCULAR., USA.""" | UNITED STATES | UKRAINE | 0 | ||
9018908400 | 1. MEDICAL PRODUCTS - BALLOON-CATHETER FOR CEREBRAL ANEURYSMS WITH A WIDE NECK, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH PROTECTION MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT """"MEDICINES AND MEDICAL PRODUCTS FOR HEALTH CARE FACILITIES HEALTH TO ENSURE THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"""" UNDER THE BUDGET PROGRAM KPKVK 2301400.- HYPERGLIDE OCCLUSION BALLOON SYSTEM / HYPERGLIDE (TM) OCCLUSION BALLOON SYSTEM, CATALOG NUMBER 104-4112 - 82 PIECES; CATALOG NUMBER 104 -4132 - 4 PIECES; CATALOG NUMBER 104-4515 - 23 PIECES; CATALOG NUMBER 104-4113 - 36 PIECES; CATALOG NUMBER 104-4520 - 1 PIECE; CATALOG NUMBER 104-4127 - 53 PIECES; TOTAL QUANTITY 199 PIECES. MANUFACTURER - MICRO THERAPEUTICS INC. DBA EV3 NEUROVASCULAR, UNITED STATES OF AMERICA.""" | UNITED STATES | UKRAINE | 0 | ||
9021909000 | 1. MEDICAL PRODUCTS - FOR ENDOVASCULAR EMBOLIZATION OF BRAIN ANEURYSMS WITH DETACHABLE MICROCOILS, WHICH INCLUDES A MICROCOIL, 1 PIECE, SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR HEALTH CARE INSTITUTIONS TO PROVIDE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"", ACCORDING TO THE BUDGET PROGRAM OF KPKVK 2301400. - SPIRAL FOR EMBOLIZATION AXIUM HELIX: CATALOG NUMBER QC-2.5-4-HELIX - 7 PIECES. CATALOG NUMBER QC-2.5-6-HELIX - 6 PIECES. TOTAL QUANTITY - 13. MANUFACTURER - MICRO THERAPEUTICS INC. DBA EV3 NEUROVASCULAR. COUNTRY OF MANUFACTURE - MEXICO. MANUFACTURED AT THE PRODUCTION SITE/SITE OF MEDTRONIC MEXICO CITY S. DE R.L. WHERE SV.""" | MEXICO | UKRAINE | 0 | ||
3004200000 | 1. PHARMACEUTICAL PRODUCTS - MEROPENEM 500MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR THE TREATMENT OF CHILDREN WITH ONCOLOGICAL AND ONCOLOGICAL HEMATOLOGICAL DISEASES, AND CARRYING OUT TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS TO CHILDREN AND ADULTS"""" UNDER THE BUDGET PROGRAM OF KPKVK 2301400, WHICH WILL BE PURCHASED IN 2023. . MEDICINAL PRODUCTS FOR HUMAN USE, PUT UP AND PACKAGED FOR RETAIL SALE. PHARMACOTHERAPEUTIC GROUP. ANTIMICROBIAL AGENTS FOR SYSTEMIC USE. CARBAPENEMS. - MEROPENEM - VISTA, POWDER FOR PREPARING A SOLUTION FOR INJECTIONS OF 500 MG; 10 VIALS WITH POWDER IN A CARDBOARD BOX. SERIES 23J03373 - 1531 PACKAGES (15310 VIALS). ACTIVE SUBSTANCES: 1 VIAL CONTAINS 570 MG OF MEROPENEM TRIHYDRATE, WHICH CORRESPONDS TO 500 MG OF MEROPENEM IN TERMS OF ANHYDROUS SUBSTANCE. MANUFACTURER - АСС DOBFAR S.P.A. (PRODUCTION, PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL, SERIES RELEASE; PRODUCTION AND QUALITY CONTROL OF STERILE MIXTURE), ITALY.""" | ITALY | UKRAINE | 0 | ||
3004900000 | 1. PHARMACEUTICAL PRODUCTS - TEMOZOLOMIDE 250 MG, WHICH IS SUPPLIED WITHIN THE FRAMEWORK OF IMPLEMENTATION OF PROGRAMS AND IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""CHEMOTHERAPY DRUGS, RADIOPHARMACEUTICALS AND ACCOMPANYING DRUGS FOR THE TREATMENT OF CANCER PATIENTS"" ACCORDING TO THE BUDGET KPKVK PROGRAM 2301400, WHICH WILL BE PURCHASED IN 2023. MEDICINAL PRODUCTS FOR HUMANS, PREPACKAGED AND PACKAGED AS FOR RETAIL TRADE, NOT IN AEROSOL PACKAGES. PHARMACOTHERAPEUTIC GROUP - ANTINEOPLASTIC AGENTS. ALKYLATING COMPOUNDS. - GLIOSOMID, 250 MG CAPSULES; 1 CAPSULE IN A SACHET; 5 SACHETS IN A CARDBOARD PACK. SERIES CM1232A - 1306 PACKAGES (6530 CAPSULES). SERIES CM1233A - 1072 PACKAGES (5360 CAPSULES). TOTAL NUMBER OF 2378 PACKAGES (11890 CAPSULES). ACTIVE SUBSTANCES: 1 CAPSULE CONTAINS 250 MG OF TEMOZOLOMIDE. MANUFACTURERS - AIGEN PHARMA LIMITED (PRODUCTION OF GLZ, PACKAGING, TESTING, SERIES RELEASE), IRELAND; MILLMOUNT HELSKEA LTD (PRIMARY AND SECONDARY PACKAGING), IRELAND.""" | IRELAND | UKRAINE | 0 | ||
9018390000 | 1. MEDICAL PRODUCTS - BIOPROSTHESIS OF THE CARDIAC AORTIC VALVE FOR TRANSCATHETER IMPLANTATION, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR HEALTH CARE INSTITUTIONS"" TO PROVIDE TREATMENT FOR PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"" UNDER THE KPKVK BUDGET PROGRAM 2301400.- CATHETER DELIVERY SYSTEM ENVEO PRO, CATALOG NUMBER ENVPRO-14 - 46 PIECES.- CATHETER DELIVERY SYSTEM ENVEO PRO, CATALOG NUMBER ENVPRO-16 - 6 PIECES. MANUFACTURER - MEDTRONIC KOREVALVE LLC. MANUFACTURED AT THE PRODUCTION SITE - MEDTRONIC IRELAND. COUNTRY OF MANUFACTURE - IE.""" | IRELAND | UKRAINE | 0 | ||
9018908400 | 1. MEDICAL PRODUCTS - BIOPROSTHESIS OF THE CARDIAC AORTIC VALVE FOR TRANSCATHETER IMPLANTATION, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR HEALTH CARE INSTITUTIONS"" TO PROVIDE TREATMENT FOR PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"" UNDER THE KPKVK BUDGET PROGRAM 2301400.- ENVEO PRO LOADING SYSTEM, CATALOG NUMBER L-ENVPRO-14 - 46 PIECES.- ENVEO PRO LOADING SYSTEM, CATALOG NUMBER L-ENVPRO -16 - 6 PIECES. MANUFACTURER - MEDTRONIC KOREVALVE LLC. MANUFACTURED AT THE PRODUCTION SITE - MEDTRONIC IRELAND. COUNTRY OF MANUFACTURE - IE.""" | IRELAND | UKRAINE | 0 | ||
9021399000 | 1. MEDICAL PRODUCTS - MECHANICAL BICUSPID HEART VALVE FOR AORTIC VALVE PROSTHETICS, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF BUDGET PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR HEALTH CARE FACILITIES HEALTH TO ENSURE THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"" UNDER THE BUDGET PROGRAM OF THE KPKVK 2301400.- MECHANICAL HEART VALVE, AORTIC AP360 MEDTRONIC OPEN PIVOT: CATALOG NUMBER 505DA22 - 12 PIECES; CATALOG NUMBER 505DA26 - 7 PIECES; GENERAL QUANTITY - 19 PIECES. MANUFACTURER - MEDTRONIC, INC. COUNTRY OF MANUFACTURE - UNITED STATES OF AMERICA.""" | UNITED STATES | UKRAINE | 0 | ||
9021399000 | 1. MEDICAL PRODUCTS - BIOPROSTHESIS OF THE CARDIAC AORTIC VALVE FOR TRANSCATHETER IMPLANTATION, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR HEALTH CARE INSTITUTIONS"" I TO PROVIDE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"" UNDER THE BUDGET PROGRAM OF THE KPKVK 2301400. - AORTIC VALVE FOR TRANSCATHETER INSTALLATION (BIOPROSTHESIS) KOREVALV EVOLYUT R: CATALOG NUMBER EVOLUTR-34 - 6 PIECES. CATALOG NUMBER EVOLUTR-29 - 30 PIECES. CATALOG NUMBER EVOLUTR-26 - 16 PIECES. TOTAL QUANTITY - 52 PIECES. MANUFACTURER - MEDTRONIK KOREVALVE LLC. MANUFACTURED AT THE PRODUCTION SITE/SITE OF MEDTRONIK MEXICO CITY S DE R.L. WHERE SV. COUNTRY OF MANUFACTURE - MX.""" | MEXICO | UKRAINE | 0 | ||
9021909000 | 1. MEDICAL PRODUCTS - A CORONARY STENT SYSTEM WITH A MEDICAL COATING FOR THE TREATMENT OF PATIENTS WITH COMPLEX AND CALCIFIED LESIONS, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF BUDGET PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT """"MEDICAL MEANS AND MEDICAL PRODUCTS FOR HEALTH CARE INSTITUTIONS TO PROVIDE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"""" ACCORDING TO THE BUDGET PROGRAM KPKVK 2301400, PURCHASED IN 2023.- XIENCE PROA CORONARY STENT SYSTEM WITH EVEROLIMUS COATING, CATALOG NUMBER 1128225-15 - 85 PIECES. CATALOG NUMBER 1128225-18 - 115 PIECES. CATALOG NUMBER 1128225-23 - 80 PIECES. CATALOG NUMBER 1128250-18 - 195 PIECES. CATALOG NUMBER 1128250-23 - 195 PIECES. CATALOG NUMBER 1128300-18 - 83 PIECES. CATALOG NUMBER 1128300-23 - 210 PIECES. CATALOG NUMBER 1128300-28 - 80 PIECES. CATALOG NUMBER 1128300-33 - 30 PIECES. CATALOG NUMBER 1128350-18 - 166 PIECES. CATALOG NUMBER 1128350-23 - 166 PIECES. CATALOG NUMBER 1128350-28 - 90 PIECES. CATALOG NUMBER 1128350-33 - 35 PIECES. CATALOG NUMBER 1128400-18 - 50 PIECES. THE TOTAL NUMBER IS 1580 PIECES. THE MANUFACTURER IS ABBOTT VASCULAR / ABBOTT VASCULAR, USA AT THE PRODUCTION FACILITY OF ABBOTT VASCULAR / ABBOTT VASCULAR, IRELAND. THE COUNTRY OF PRODUCTION IS IRELAND.""" | IRELAND | UKRAINE | 0 | ||
9021909000 | 1. MEDICAL PRODUCTS - A CORONARY STENT SYSTEM WITH A MEDICAL COATING FOR THE TREATMENT OF PATIENTS WITH MULTIPLE LESIONS, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF BUDGET PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT """"MEDICAL PRODUCTS AND MEDICAL DEVICES FOR HEALTH CARE FACILITIES TO PROVIDE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"""" UNDER THE BUDGET PROGRAM OF KPKVK 2301400, PURCHASED IN 2023.- XIENCE PROA CORONARY STENT-SYSTEM WITH EVEROLIMUS COATING, CATALOG NUMBER 1128225- 18 - 128 PIECES. CATALOG NUMBER 1128250-15 - 150 PIECES. CATALOG NUMBER 1128250-18 - 150 PIECES. CATALOG NUMBER 1128275-15 - 190 PIECES. CATALOG NUMBER 1128275-18 - 253 PIECES. CATALOG NUMBER 1128300-18 - 253 PIECES. CATALOG NUMBER 1128300-23 - 317 PIECES. CATALOG NUMBER 1128300-33 - 102 PIECES. CATALOG NUMBER 1128350-18 - 168 PIECES. CATALOG NUMBER 1128350-23 - 168 PIECES. CATALOG NUMBER 1128350-33 - 152 PIECES. CATALOG NUMBER 1128400-15 - 69 PIECES. THE TOTAL NUMBER IS 2100 PIECES. THE MANUFACTURER IS ABBOTT VASCULAR / ABBOTT VASCULAR, USA AT THE PRODUCTION FACILITY OF ABBOTT VASCULAR / ABBOTT VASCULAR, IRELAND. THE COUNTRY OF PRODUCTION IS IRELAND.""" | IRELAND | UKRAINE | 0 | ||
9021909000 | 1. MEDICAL PRODUCTS - A CORONARY STENT SYSTEM WITH A MEDICAL COATING FOR THE TREATMENT OF PATIENTS WITH COMPLEX AND CALCIFIED LESIONS, WHICH ARE SUPPLIED AS PART OF THE IMPLEMENTATION OF BUDGET PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT """"MEDICAL MEANS AND MEDICAL PRODUCTS FOR HEALTH CARE INSTITUTIONS TO PROVIDE TREATMENT OF PATIENTS WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES"""" ACCORDING TO THE BUDGET PROGRAM KPKVK 2301400, PURCHASED IN 2023.- XIENCE PROA CORONARY STENT SYSTEM WITH EVEROLIMUS COATING, CATALOG NUMBER 1128300-18 - 112 PIECES. CATALOG NUMBER 1128350-18 - 4 PIECES. CATALOG NUMBER 1128350-23 - 4 PIECES. THE TOTAL NUMBER IS 120 PIECES. THE MANUFACTURER IS ABBOTT VASCULAR / ABBOTT VASCULAR, USA AT THE PRODUCTION FACILITY OF ABBOTT VASCULAR / ABBOTT VASCULAR, IRELAND. THE COUNTRY OF PRODUCTION IS IRELAND.""" | IRELAND | UKRAINE | 0 | ||
3004900000 | 1. PHARMACEUTICAL PRODUCTS - CABAZITAXEL 60 MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""CHEMOTHERAPY DRUGS, RADIOPHARMACEUTICALS AND ACCOMPANYING DRUGS FOR THE TREATMENT OF ONCOLOGICAL PATIENTS"" ACCORDING TO THE BUDGET KPKVK PROGRAM 2301400. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE, NOT IN AEROSOL PACKAGES. PHARMACOTHERAPEUTIC GROUP. ANTINEOPLASTIC AGENTS. TAXANES. ATX CODE L01CD04.- CABAZITAXEL ACCORD CONCENTRATE FOR SOLUTION FOR INFUSION, 20 MG/ML, BOTTLE OF 60 MG/3 ML, 1 BOTTLE IN A PACK. SERIES M2308474 - 1198 PACKAGES (VIALS). ACTIVE SUBSTANCES: 1 ML CONTAINS: CABAZITAXEL - 20.00 MG. MANUFACTURERS - ACCORD HELSKEA B.V. (RESPONSIBLE FOR THE RELEASE OF THE SERIES)/ACCORD HELSKEA POLSKA SP. WITH O.O. (RESPONSIBLE FOR SERIES RELEASE), NETHERLANDS/POLANDACCORD HELSKEA LIMITED (ADDITIONAL SECONDARY PACKAGING)/WESSLING HUNGERI KFT. (PHYSICAL AND CHEMICAL CONTROL), GREAT BRITAIN/HUNGARY INTAS PHARMACEUTICALS LIMITED (PRODUCTION OF MEDICINAL PRODUCT, PRIMARY AND SECONDARY PACKAGING)/LABANALYSIS S.R.L. (CHEMICAL-PHYSICAL, MICROBIOLOGICAL CONTROL), INDIA/ITALY FUNDACIO DAU LABORATORIES (CHEMICAL-PHYSICAL, MICROBIOLOGICAL CONTROL, ADDITIONAL SECONDARY PACKAGING, RESPONSIBLE FOR SERIES RELEASE)/PRISPEK JACEK KARONSKYI (ADDITIONAL SECONDARY PACKAGING)/SYNOPTYZ INDUSTRIAL SP. WITH O.O. (ADDITIONAL SECONDARY PACKAGING), SPAIN/POLAND/POLANDPHARMADOX HELSKEA LIMITED (CHEMICAL-PHYSICAL, MICROBIOLOGICAL CONTROL, ADDITIONAL SECONDARY PACKAGING, RESPONSIBLE FOR SERIES RELEASE)/PHARMAVALID LTD., MICROBIOLOGICAL LABORATORY (CHEMICAL-PHYSICAL, MICROBIOLOGICAL CONTROL), HUNGARY/MALTACOUNTRY OF PRODUCTION : IN.""" | INDIA | UKRAINE | 0 | ||
3004900000 | 1. PHARMACEUTICAL PRODUCTS - AZACITIDINE 100 MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""CHEMOTHERAPEUTIC DRUGS, RADIOPHARMACEUTICALS AND ACCOMPANYING DRUGS FOR THE TREATMENT OF ONCOLOGICAL PATIENTS"" UNDER THE BUDGET PROGRAM OF THE KPKVK 2301400.MEDICINES FOR HUMANS, PUT UP FOR RETAIL SALE, NOT IN AEROSOL CONTAINERS. DOES NOT CONTAIN NARCOTICS, PRECURSORS AND PSYCHOTROPIC SUBSTANCES. PHARMACOTHERAPEUTIC GROUP. ANTITUMOR DRUGS. PYRIMIDINE ANALOGUES. ATX CODE L01BC07.- AZACITIDINE ACCORD, POWDER FOR PREPARATION OF SUSPENSION FOR INJECTIONS, 25 MG/ML, BOTTLE OF 100 MG, 1 BOTTLE IN A PACK. SERIES P2300344A - 3385 PACKAGES (VIALS). ACTIVE INGREDIENTS: 1 BOTTLE CONTAINS: AZACITIDINE 105 MG. MANUFACTURER - ACCORD HELSKEA B.V. (RESPONSIBLE FOR THE RELEASE OF THE SERIES)/ACCORD HELSKEA POLSKA SP. Z.O.O. (RESPONSIBLE FOR SERIES RELEASE), NETHERLANDS/POLANDACCORD HELSKEA LIMITED (ADDITIONAL SECONDARY PACKAGING)/BROKACEF HELSKEA LOGISTICS B.V. (ADDITIONAL SECONDARY PACKAGING)/PRISPEK JACEK KARONSKI (ADDITIONAL SECONDARY PACKAGING), GREAT BRITAIN/NETHERLANDS/POLAND WESSLING HUNGARY KFT. (PHYSICAL AND CHEMICAL CONTROL) / PHARMAVALID LTD., MICROBIOLOGICAL LABORATORY (CHEMICAL, PHYSICAL, MICROBIOLOGICAL CONTROL), HUNGARY/HUNGARYINTAS PHARMACEUTICALS LIMITED (PRODUCTION OF MEDICINE, PRIMARY AND SECONDARY PACKAGING)/SYNOPTYZ INDUSTRIAL SP. WITH O.O. (ADDITIONAL SECONDARY PACKAGING), INDIA/POLAND FUNDACIO DOW LABORATORIES (CHEMICAL-PHYSICAL, MICROBIOLOGICAL CONTROL, ADDITIONAL SECONDARY PACKAGING, RESPONSIBLE FOR BATCH RELEASE)/PHARMADOX HELSKEA LTD. (CHEMICAL-PHYSICAL, MICROBIOLOGICAL CONTROL, ADDITIONAL SECONDARY PACKAGING), SPAIN/MALTA""" | INDIA | UKRAINE | 0 | ||
3002150000 | 1. PHARMACEUTICAL PRODUCTS - ADALIMUMAB 40 MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES FOR THE TREATMENT OF CITIZENS SUFFERING FROM A RESISTANT FORM OF JUVENILE RHEUMATOID ARTHRITIS"" "" UNDER THE KPKVK BUDGET PROGRAM 2301400. PHARMACOTHERAPEUTIC GROUP. IMMUNOSUPPRESSANTS. INHIBITORS OF TUMOR NECROSIS FACTOR-ALPHA. ADALIMUMAB. ATC CODE L04A B04.- KHYRIMOZ 40, SOLUTION FOR INJECTION, 40 MG/ 0.8 ML, 0.8 ML OF SOLUTION IN A PRE-FILLED SYRINGE; 2 PRE-FILLED SYRINGES IN BLISTERS IN A CARDBOARD BOX. SERIES NJ2025 - 2542 PACKAGES (5084 SYRINGES). ACTIVE SUBSTANCES: 1 PRE-FILLED SYRINGE (0.8 ML) CONTAINS: ADALIMUMAB 40 MG. MANUFACTURER - NOVARTIS PHARMA STEIN AG (CONTROL (CHEMICAL /PHYSICAL)), SWITZERLAND NOVARTIS PHARMA AG (BATCH CONTROL (BIOLOGICAL)), SWITZERLAND LEK D.D., PE MENGESH PRODUCTION (BATCH CONTROL (BIOLOGICAL))/SYNLAB ANALYTICS AND SERVICES SWITZERLAND AG (BATCH CONTROL (BIOLOGICAL)), SLOVENIA/SWITZERLAND SANDOZ GMBH - PRODUCTION SITE ASEPTIC MEDICINES SHAFTENAU (FULL PRODUCTION CYCLE)/SANDOZ GMBH - PRODUCTION SITE BIOTECHNOLOGICAL MEDICINAL SUBSTANCES KUNDL (BT LSK) (BATCH CONTROL (MICROBIOLOGICAL - STERILE INDICATORS, MICROBIOLOGICAL - NON-STERILE INDICATORS)), AUSTRIA/AUSTRIAEUROFINS FAST GMBH (BATCH CONTROL (CHEMICAL/PHYSICAL)), GERMANY""" | AUSTRIA | UKRAINE | 0 | ||
3002150000 | 1. PHARMACEUTICAL PRODUCTS - TRASTUZUMAB 150 MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""CHEMOTHERAPY DRUGS, RADIOPHARMACEUTICALS AND ACCOMPANYING DRUGS FOR THE TREATMENT OF CANCER PATIENTS"" ACCORDING TO BUDGET PROGRAM KPKVK 2301400. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE, NOT IN AEROSOL PACKAGES. PHARMACOTHERAPEUTIC GROUP: ANTINEOPLASTIC AGENTS, MONOCLONAL ANTIBODIES. ATC CODE: L01FD01, L01XC03.- ONTRUSANT, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSIONS IN A VIAL, 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCE: 1 VIAL CONTAINS: TRASTUZUMAB 150 MG), SERIES F2103010, TOTAL - 17033 PCS.,- ONTRUSANT, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSIONS IN A VIAL, 1 VIAL IN A CARDBOARD BOX (ACTIVE INGREDIENT: 1 VIAL CONTAINS: TRASTUZUMAB 150 MG), SERIES F2103103, TOTAL - 1708 PCS.,- ONTRUSANT, POWDER FOR CONCENTRATE FOR SOLUTION FOR" | FRANCE | UKRAINE | 0 | ||
3004900000 | 1. PHARMACEUTICAL PRODUCTS - DEFERASIROX 180MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES AND MEDICAL PRODUCTS FOR THE TREATMENT OF CHILDREN WITH ONCOLOGICAL AND ONCOHEMATOLOGICAL DISEASES, AND TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FOR CHILDREN AND ADULTS UNDER THE KPKVK BUDGET PROGRAM 2301400. MEDICINAL PRODUCTS FOR HUMANS, PREPACKAGED AND PACKAGED AS FOR RETAIL TRADE. PHARMACOTHERAPEUTIC GROUP. MEANS THAT FORM CHELATE COMPOUNDS WITH IRON. - DEFERASIROX-VISTA, FILM-COATED TABLETS, 180 MG EACH, 10 TABLETS IN A BLISTER; 3 BLISTERS IN A CARDBOARD BOX - 299 PACKAGES (8970 TABLETS). SERIES 2204158A. ACTIVE SUBSTANCES: 1 FILM-COATED TABLET CONTAINS 180 MG OF DEFERASIROX. MANUFACTURER - SINTON HISPANIA, S.L. (QUALITY CONTROL, SERIES RELEASE), SPAIN; SINTON CHILE LTDA. (PRODUCTION, PRIMARY, SECONDARY PACKAGING, CON" | CHILE | UKRAINE | 0 | ||
3002120000 | 1. PHARMACEUTICAL PRODUCT - ANTI-INHIBITOR COAGULANT COMPLEX SUPPLIED WITHIN THE IMPLEMENTATION OF PROGRAMS AND IMPLEMENTATION OF CENTRALIZED HEALTH PROTECTION MEASURES, WITHIN THE IMPLEMENTATION OF THE KPKVK BUDGET PROGRAM 2301400 """"Z PROVISION OF MEDICAL MEASURES OF SEPARATE STATE PROGRAMS AND COMPLEX PROGRAM MEASURES""""; KEKV 2610 ""SUBSIDIES AND CURRENT TRANSFERS TO ENTERPRISES (INSTITUTIONS, ORGANIZATIONS)"" UNDER MANAGED ACCESS CONTRACT. MEDICINES FOR HUMANS, PACKAGED AS FOR RETAIL TRADE. PHARMACOTHERAPEUTIC GROUP . BLOOD COAGULATION FACTORS. PROTEINS WITH ACTIVITY SHUNTING INHIBITORS TO FACTOR VIII. CODE ATX B02B D03.- FAB, POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 UNITS; POWDER IN VIALS AND SOLVENT (WATER FOR INJECTIONS) OF 20 ML IN VIALS. 1 POWDER VIAL EACH COMPLETE WITH 1 SOLVENT VIAL AND BAXJECT II HIGH FLOW DILUTION DEVICE AND INJECTION SET (1 DISPOSABLE SYRINGE, 1 DISPOSABLE NEEDLE, 1 BUTTERFLY NEEDLE) IN A BOX. SERIES F2B003AA - 514 PACKAGING (257,000 IU). ACTIVE SUBSTANCES: 1 VIAL WITH POWDER CONTAINS: HUMAN PLASMA PROTEIN - 200-600 MG WITH ACTIVITY SHUNTING INHIBITORS TO HUMAN BLOOD COAGULATION FACTOR VIII - 500 UNITS ..MANUFACTURERS - TAKEDA MANUFACTURING AUSTRIA AG ( BATCH AUTHORIZATION; PRODUCTION, QUALITY CONTROL AND STABILITY TESTING, PRIMARY PACKAGING AND SECONDARY PACKAGING OF EYES, QUALITY CONTROL AND STABILITY TESTING AND TOXINS AND STERILITY)), AUSTRIA; SIGFRIED HAMELN GMBH (SOLVENT PRODUCTION AND QUALITY CONTROL), GERMANY | AUSTRIA | UKRAINE | 0 | ||
3002120000 | 1. PHARMACEUTICAL PRODUCT - ANTI-INHIBITOR COAGULANT COMPLEX SUPPLIED WITHIN THE IMPLEMENTATION OF PROGRAMS AND IMPLEMENTATION OF CENTRALIZED HEALTH PROTECTION MEASURES, WITHIN THE IMPLEMENTATION OF THE KPKVK BUDGET PROGRAM 2301400 """"Z PROVISION OF MEDICAL MEASURES OF SEPARATE STATE PROGRAMS AND COMPLEX PROGRAM MEASURES""""; KEKV 2610 ""SUBSIDIES AND CURRENT TRANSFERS TO ENTERPRISES (INSTITUTIONS, ORGANIZATIONS)"" UNDER MANAGED ACCESS CONTRACT. MEDICINES FOR HUMANS, PACKAGED AS FOR RETAIL TRADE. PHARMACOTHERAPEUTIC GROUP . BLOOD COAGULATION FACTORS. PROTEINS WITH ACTIVITY SHUNTING INHIBITORS TO FACTOR VIII. CODE ATX B02B D03.- FAB, POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1000 UNITS; POWDER IN VIALS AND SOLVENT (WATER FOR INJECTIONS) OF 20 ML IN VIALS; 1 POWDER VIAL EACH COMPLETE WITH 1 SOLVENT VIAL AND BAXJECT II HIGH FLOW DILUTION DEVICE AND INJECTION SET (1 DISPOSABLE SYRINGE, 1 DISPOSABLE NEEDLE, 1 BUTTERFLY NEEDLE) IN A BOX. SERIES F2A043AF - 4177 PACKAGING (4177000 IU). ACTIVE INGREDIENTS: 1 VIAL WITH POWDER CONTAINS: HUMAN PLASMA PROTEIN – 400–1200 MG WITH ACTIVITY BYPASSING INHIBITORS TO HUMAN BLOOD COAGULATION FACTOR VIII, 10 00 UNITS OF MANUFACTURERS - TAKEDA MANUFACTURING AUSTRIA AG (LICENSE ON BATCH RELEASE; PRODUCTION, QUALITY CONTROL AND STABILITY TESTING, PRIMARY PACKAGING AND SECONDARY PACKAGING OF EYES; QUALITY CONTROL AND STABILITY TESTING OF EYES WE AND STERILITY), AUSTRIASIGFRID HAMELN GMBH (SOLVENT PRODUCTION AND QUALITY CONTROL), GERMANY | AUSTRIA | UKRAINE | 0 |
No Pay, No Delay - 5 days Your Way!
Learn How our platform works in just 20 minutes!
Free Import-Export Sample data-One Click Away!
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
See all that you can accomplish with Eximpedia